Cover Image
Market Research Report

North America Cardiac Rhythm Management Devices Market Outlook to 2025

Published by GlobalData Product code 357516
Published Content info 155 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Cardiac Rhythm Management Devices Market Outlook to 2025
Published: May 1, 2018 Content info: 155 Pages
Description

GlobalData's new report, North America Cardiac Rhythm Management Devices Market Outlook to 2025, provides key market data on the North America Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
Product Code: GDMECR0794DB

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 7

2 Introduction 9

  • 2.1 What Is This Report About? 9
  • 2.2 Cardiac Rhythm Management Devices Segmentation 9
  • 2.3 Definitions of Markets Covered in the Report 10

3 Cardiac Rhythm Management Devices Market, North America 12

  • 3.1 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025 12
  • 3.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025 14
  • 3.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 17
  • 3.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 19
  • 3.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2017 22

4 Cardiac Rhythm Management Devices Market, Canada 24

  • 4.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2015-2025 24
    • 4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2015-2025 27
    • 4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2015-2025 30
    • 4.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2015-2025 33
  • 4.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025 36
    • 4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2015-2025 39
    • 4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2015-2025 42
    • 4.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2015-2025 45
  • 4.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2015-2025 48
  • 4.4 Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), 2017 50
  • 4.5 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2017 51

5 Cardiac Rhythm Management Devices Market, Mexico 53

  • 5.1 Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2015-2025 53
    • 5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2015-2025 56
    • 5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2015-2025 58
    • 5.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2015-2025 60
  • 5.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025 62
    • 5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2015-2025 65
    • 5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2015-2025 67
    • 5.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2015-2025 69
  • 5.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2015-2025 71
  • 5.4 Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), 2017 73
  • 5.5 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2017 74

6 Cardiac Rhythm Management Devices Market, United States 76

  • 6.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025 76
    • 6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025 79
    • 6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025 81
    • 6.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025 83
  • 6.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 85
    • 6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025 88
    • 6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025 90
    • 6.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025 92
  • 6.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($) , 2015-2025 94
  • 6.4 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2017 96
  • 6.5 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2017 97

7 Overview of Key Companies in North America Cardiac Rhythm Management Devices Market 99

  • 7.1 Medtronic Plc 99
    • 7.1.1 Company Overview 99
  • 7.2 Abbott Laboratories 99
    • 7.2.1 Company Overview 99
  • 7.3 Biotronik AG 99
    • 7.3.1 Company Overview 99
  • 7.4 Boston Scientific Corp 99
    • 7.4.1 Company Overview 99

8 Cardiac Rhythm Management Devices Market Pipeline Products 100

9 Recent Developments 102

  • 9.1 Corporate Communications 102
    • 9.1.1 Apr 15, 2018: Genentech to Present Phase Ib/II Study Results of RG6206 102
    • 9.1.2 Apr 10, 2018: iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors 102
    • 9.1.3 Mar 13, 2018: Orthofix Announces Appointment of John Sicard to Board of Directors 103
    • 9.1.4 Feb 13, 2018: Proteus Digital Health Appoints Joseph Swedish As Board Director 103
    • 9.1.5 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America 103
    • 9.1.6 Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update 104
    • 9.1.7 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 104
    • 9.1.8 Oct 11, 2017: New Data Shows That for Some Patients, Deep Brain Stimulation May Address Chronic Depression 105
    • 9.1.9 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 106
    • 9.1.10 Sep 05, 2017: Former U. S. Surgeon General Dr. Regina Benjamin Joins the Board of Proteus Digital Health 107
    • 9.1.11 Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer 107
    • 9.1.12 Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint 108
    • 9.1.13 Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint 108
    • 9.1.14 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 109
  • 9.2 Financial Announcements 109
    • 9.2.1 Apr 25, 2018: Boston Scientific Announces Results For First Quarter 2018 109
    • 9.2.2 Apr 16, 2018: USRM Reports 2017 Financial Results 111
    • 9.2.3 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 112
    • 9.2.4 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 113
    • 9.2.5 Feb 26, 2018: Orthofix International Reports Fourth Quarter And Fiscal 2017 Financial Results 115
    • 9.2.6 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 116
    • 9.2.7 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 116
    • 9.2.8 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 118
    • 9.2.9 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 119
    • 9.2.10 Jan 09, 2018: Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results 120
    • 9.2.11 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 121
    • 9.2.12 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 121
    • 9.2.13 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 122
    • 9.2.14 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 123
    • 9.2.15 Nov 01, 2017: iRhythm Technologies Announces Third Quarter 2017 Financial Results And Raises Guidance For Full Year 2017 124
    • 9.2.16 Oct 30, 2017: Orthofix International Reports Third Quarter 2017 Financial Results 125
    • 9.2.17 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 125
    • 9.2.18 Oct 25, 2017: Bard Announces Third Quarter Results 126
    • 9.2.19 Sep 26, 2017: Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test 128
    • 9.2.20 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 130
    • 9.2.21 Aug 29, 2017: Medovex Receives Regulatory Approval from Australia's Therapeutic Goods Administration for its DenerveX System 131
    • 9.2.22 Aug 15, 2017: CareRay Exhibits At FIME 2017 133
    • 9.2.23 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 134

9.2.24 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History 134

    • 9.2.25 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 135
    • 9.2.26 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 136
    • 9.2.27 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 136
    • 9.2.28 Aug 02, 2017: iRhythm Technologies Announces Second Quarter 2017 Financial Results 136
    • 9.2.29 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 137
    • 9.2.30 Jun 21, 2017: Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe 139
    • 9.2.31 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 139
    • 9.2.32 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 140
    • 9.2.33 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 141
    • 9.2.34 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 142
  • 9.3 Legal And Regulatory 142
    • 9.3.1 Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations 142
    • 9.3.2 Aug 03, 2017: Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute 143
    • 9.3.3 May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 143
  • 9.4 Other Significant Developments 144
    • 9.4.1 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 144
    • 9.4.2 Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds 144
    • 9.4.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 145
    • 9.4.4 Jun 01, 2017: Nexus Pharmaceuticals Receives FDA Approval for Sodium Nitroprusside Injection 146
  • 9.5 Product News 147
    • 9.5.1 Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams 147
  • 9.6 Strategy And Business Planning 147
    • 9.6.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 147
    • 9.6.2 Dec 11, 2017: Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura 148

10 Appendix 149

  • 10.1 Research Methodology 150
    • 10.1.1 Coverage 150
    • 10.1.2 Secondary Research 150
    • 10.1.3 Primary Research 151
    • 10.1.4 Market Modeling and Forecasting 152
    • 10.1.5 Company Share Analysis 153
    • 10.1.6 Distribution Share Analysis 154
    • 10.1.7 Benchmarking 154
  • 10.2 GlobalData Consulting 154
  • 10.3 Contact Us 155
  • 10.4 Disclaimer 155

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 13
  • Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 15
  • Table 3: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 16
  • Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 18
  • Table 5: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2020 20
  • Table 6: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2021-2025 21
  • Table 7: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2017 23
  • Table 8: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020 25
  • Table 9: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025 26
  • Table 10: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2020 28
  • Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2021-2025 29
  • Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2020 31
  • Table 13: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2021-2025 32
  • Table 14: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2020 34
  • Table 15: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2021-2025 35
  • Table 16: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2020 37
  • Table 17: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2021-2025 38
  • Table 18: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2020 40
  • Table 19: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2021-2025 41
  • Table 20: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2020 43
  • Table 21: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2021-2025 44
  • Table 22: Pacemakers Market, Canada, Volume (Units), 2015-2020 46
  • Table 23: Pacemakers Market, Canada, Volume (Units), 2021-2025 47
  • Table 24: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2015-2020 48
  • Table 25: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2021-2025 49
  • Table 26: Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 50
  • Table 27: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 52
  • Table 28: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020 54
  • Table 29: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025 55
  • Table 30: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2020 57
  • Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2021-2025 57
  • Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2020 59
  • Table 33: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2021-2025 59
  • Table 34: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2020 61
  • Table 35: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2021-2025 61
  • Table 36: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2020 63
  • Table 37: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2021-2025 64
  • Table 38: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2015-2020 66
  • Table 39: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2021-2025 66
  • Table 40: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2015-2020 68
  • Table 41: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2021-2025 68
  • Table 42: Pacemakers Market, Mexico, Volume (Units), 2015-2020 70
  • Table 43: Pacemakers Market, Mexico, Volume (Units), 2021-2025 70
  • Table 44: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2015-2020 71
  • Table 45: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2021-2025 72
  • Table 46: Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 73
  • Table 47: Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 75
  • Table 48: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 77
  • Table 49: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 78
  • Table 50: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2020 80
  • Table 51: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2021-2025 80
  • Table 52: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2020 82
  • Table 53: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2021-2025 82
  • Table 54: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2020 84
  • Table 55: Pacemakers Market, United States, Revenue ($m), USD Constant, 2021-2025 84
  • Table 56: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2020 86
  • Table 57: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2021-2025 87
  • Table 58: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2020 89
  • Table 59: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2021-2025 89
  • Table 60: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2020 91
  • Table 61: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2021-2025 91
  • Table 62: Pacemakers Market, United States, Volume (Units), 2015-2020 93
  • Table 63: Pacemakers Market, United States, Volume (Units), 2021-2025 93
  • Table 64: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2015-2020 94
  • Table 65: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2021-2025 95
  • Table 66: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 96
  • Table 67: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 98
  • Table 68: Cardiac Rhythm Management Devices Market Pipeline Products 100
  • Table 69: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 152

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 12
  • Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 14
  • Figure 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 17
  • Figure 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 19
  • Figure 5: Cardiac Rhythm Management Devices Market, North America, Company Share (%) 2017 22
  • Figure 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025 24
  • Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2025 27
  • Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2025 30
  • Figure 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2025 33
  • Figure 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025 36
  • Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2025 39
  • Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2025 42
  • Figure 13: Pacemakers Market, Canada, Volume (Units), 2015-2025 45
  • Figure 14: Cardiac Rhythm Management Devices Market, Canada, Company Share (%) 2017 51
  • Figure 15: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025 53
  • Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2025 56
  • Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2025 58
  • Figure 18: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2025 60
  • Figure 19: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025 62
  • Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2015-2025 65
  • Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2015-2025 67
  • Figure 22: Pacemakers Market, Mexico, Volume (Units), 2015-2025 69
  • Figure 23: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%) 2017 74
  • Figure 24: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 76
  • Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2025 79
  • Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2025 81
  • Figure 27: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2025 83
  • Figure 28: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 85
  • Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2025 88
  • Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2025 90
  • Figure 31: Pacemakers Market, United States, Volume (Units), 2015-2025 92
  • Figure 32: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2017 97
Back to Top